Finding 512277 (2023-003)

Significant Deficiency
Requirement
P
Questioned Costs
-
Year
2023
Accepted
2024-11-26
Audit: 330028
Organization: Center on Halsted (IL)
Auditor: Rsm US LLP

AI Summary

  • Core Issue: The Center will file its data collection form late, missing the March 30, 2024 deadline.
  • Impacted Requirements: This violates 2 CFR 200.512(a), which mandates timely submission of audit reports.
  • Recommended Follow-Up: Implement better processes to ensure timely filing with the Federal Audit Clearinghouse.

Finding Text

Finding 2023-003: Data collection form filing Identification of federal programs: All Assistance Listing Numbers included on the schedule of expenditures of federal awards for the year ended June 30, 2023. Criteria: 2 CFR 200.512(a) requires that the data collection form and reporting package must be submitted within the earlier of 30 calendar days after receipt of the auditor’s report, or nine months after the end of the audit period. Condition: The Center’s data collection form for the year ended June 30, 2023 will be filed after the March 30, 2024 nine month deadline, making it a late filing. Cause: The audit was not completed by March 31, 2023, due to turnover at the Center and timeliness of information being available to complete the audit. Effect: The Center was not in compliance with the Uniform Guidance (2 CFR 200.512). Questioned costs: None Context: The June 30, 2023 Single Audit reporting package. Repeat finding: No Recommendation: We recommend that the Center implement processes and controls to ensure the reporting package is filed timely with the Federal Audit Clearinghouse. Views of responsible officials: Management agrees with this finding. Please see corrective action plan attached.

Categories

Reporting

Other Findings in this Audit

  • 512254 2023-001
    Material Weakness
  • 512255 2023-002
    Material Weakness
  • 512256 2023-003
    Significant Deficiency
  • 512257 2023-003
    Significant Deficiency
  • 512258 2023-003
    Significant Deficiency
  • 512259 2023-003
    Significant Deficiency
  • 512260 2023-003
    Significant Deficiency
  • 512261 2023-003
    Significant Deficiency
  • 512262 2023-003
    Significant Deficiency
  • 512263 2023-003
    Significant Deficiency
  • 512264 2023-003
    Significant Deficiency
  • 512265 2023-003
    Significant Deficiency
  • 512266 2023-003
    Significant Deficiency
  • 512267 2023-003
    Significant Deficiency
  • 512268 2023-003
    Significant Deficiency
  • 512269 2023-003
    Significant Deficiency
  • 512270 2023-003
    Significant Deficiency
  • 512271 2023-003
    Significant Deficiency
  • 512272 2023-003
    Significant Deficiency
  • 512273 2023-003
    Significant Deficiency
  • 512274 2023-003
    Significant Deficiency
  • 512275 2023-003
    Significant Deficiency
  • 512276 2023-003
    Significant Deficiency
  • 512278 2023-003
    Significant Deficiency
  • 512279 2023-001
    Material Weakness
  • 512280 2023-002
    Material Weakness
  • 512281 2023-001
    Material Weakness
  • 512282 2023-002
    Material Weakness
  • 1088696 2023-001
    Material Weakness
  • 1088697 2023-002
    Material Weakness
  • 1088698 2023-003
    Significant Deficiency
  • 1088699 2023-003
    Significant Deficiency
  • 1088700 2023-003
    Significant Deficiency
  • 1088701 2023-003
    Significant Deficiency
  • 1088702 2023-003
    Significant Deficiency
  • 1088703 2023-003
    Significant Deficiency
  • 1088704 2023-003
    Significant Deficiency
  • 1088705 2023-003
    Significant Deficiency
  • 1088706 2023-003
    Significant Deficiency
  • 1088707 2023-003
    Significant Deficiency
  • 1088708 2023-003
    Significant Deficiency
  • 1088709 2023-003
    Significant Deficiency
  • 1088710 2023-003
    Significant Deficiency
  • 1088711 2023-003
    Significant Deficiency
  • 1088712 2023-003
    Significant Deficiency
  • 1088713 2023-003
    Significant Deficiency
  • 1088714 2023-003
    Significant Deficiency
  • 1088715 2023-003
    Significant Deficiency
  • 1088716 2023-003
    Significant Deficiency
  • 1088717 2023-003
    Significant Deficiency
  • 1088718 2023-003
    Significant Deficiency
  • 1088719 2023-003
    Significant Deficiency
  • 1088720 2023-003
    Significant Deficiency
  • 1088721 2023-001
    Material Weakness
  • 1088722 2023-002
    Material Weakness
  • 1088723 2023-001
    Material Weakness
  • 1088724 2023-002
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
21.027 Covid-19-Coronavirus State and Local Fiscal Recovery Funds $163,350
14.241 Housing Opportunities for Persons with Aids $93,139
93.940 Hiv Prevention Activities_health Department Based $74,270
93.914 Hiv Emergency Relief Project Grants $46,183
16.034 Covid-19-Coronavirus Emergency Supplemental Funding Program $33,115
93.368 21st Century Cures Act - Precision Medicine Initiative $22,612
16.575 Crime Victim Assistance $22,015
97.008 Non-Profit Security Program $242